This activity is designed to optimize care of children with pediatric hematologic disorders and enable care coordination with pediatric oncology and pediatric bone marrow transplant. We intend to identify barriers to care in order to optimize diagnosis and therapy. We discuss new developments in treatment of hematology patients for example the development of new long-acting factor concentrates for the treatment of hemophilia, novel agents for the treatment of chronic ITP as well as novel diagnostic approaches for rare disorders.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Physicians, Physician Assistants, Nurse Practitioners, Nurses
Given a child with new onset of sever clinical bleering will discuss optimal diagnostic approach and initial therapy.
Given a child with new onset thrombocytopenia discuss appropriate diagnostic approach as advocated by the American society of hematology and initial therapy when indicated.
Will discuss new developments in treatment of hemophilia in order to optimize care and minimize demands on the family.
Activity Director: J. Paul Scott, MD
Additional Planner: H. McCown, APP
Speaker: J. Paul Scott, MD
All persons in control of content have NO relevant financial relationships to disclose.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.